Sympathetic overactivity in the development of eyelid retraction in a patient with euthyroid Graves' disease evaluated by accommodation
- PMID: 11200944
- DOI: 10.1507/endocrj.47.623
Sympathetic overactivity in the development of eyelid retraction in a patient with euthyroid Graves' disease evaluated by accommodation
Abstract
It is known that measurement of accommodation is useful to evaluate the sympathetic activity of intraocular muscles. To find if sympathetic overactivity is involved in eyelid retraction in euthyroid Graves' disease, we measured accommodation in two patients with this disease, whose serum concentrations of free T3, free T4 and TSH were within reference ranges. Accommodation was measured with a computer-assisted infrared optometer with an iriscoder, and the results were expressed as the change in the eye's refractive power (in diopters) in response to the movement of a target beam. In patient 1, the accommodation amplitude was low, indicating sympathetic overactivity. This amplitude rose to near the reference range when timolol maleate drops were used, and the eyelid retraction disappeared when guanethidine drops were given. During the use of guanethidine drops, accommodation remained normal. In patient 2, who had normal accommodation, eyelid retraction did not change with guanethidine administration, but improved with intravenous methylprednisolone pulse therapy. These two cases suggested that even in euthyroid Graves' disease, eyelid retraction is caused by sympathetic overactivity, and pulse therapy with methylprednisolone may be effective for eyelid retraction when guanethidine drops are not effective.
Similar articles
-
Sympathetic overactivity of intraocular muscles evaluated by accommodation in patients with hyperthyroidism.Thyroid. 1996 Aug;6(4):289-93. doi: 10.1089/thy.1996.6.289. Thyroid. 1996. PMID: 8875748 Clinical Trial.
-
Effect of darkness on upper eyelid position.Ophthalmic Plast Reconstr Surg. 2005 Mar;21(2):112-6. doi: 10.1097/01.iop.0000155523.99318.af. Ophthalmic Plast Reconstr Surg. 2005. PMID: 15778664
-
Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.J Clin Endocrinol Metab. 1993 Apr;76(4):928-32. doi: 10.1210/jcem.76.4.7682562. J Clin Endocrinol Metab. 1993. PMID: 7682562
-
Graves' ophthalmopathy--a clinical review.Aust N Z J Ophthalmol. 1990 Aug;18(3):239-42. Aust N Z J Ophthalmol. 1990. PMID: 2261168 Review.
-
Graves' eye disease: orbital compliance and other physical measurements.Trans Am Ophthalmol Soc. 1984;82:492-598. Trans Am Ophthalmol Soc. 1984. PMID: 6398935 Free PMC article. Review. No abstract available.
Cited by
-
Graves' orbitopathy development in thyroid cancer patients: a 16-year nationwide cohort study in South Korea.Eye (Lond). 2024 Oct;38(15):2955-2959. doi: 10.1038/s41433-024-03197-9. Epub 2024 Jun 28. Eye (Lond). 2024. PMID: 38942911
-
Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease.Clin Ophthalmol. 2018 Apr 19;12:739-746. doi: 10.2147/OPTH.S158967. eCollection 2018. Clin Ophthalmol. 2018. PMID: 29719374 Free PMC article.
-
Static and dynamic pupillary features in graves disease without orbitopathy.Int Ophthalmol. 2024 Nov 12;44(1):428. doi: 10.1007/s10792-024-03355-8. Int Ophthalmol. 2024. PMID: 39531136